Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide plus PEG for bowel preparation before colonoscopy
ChiCTR2200065832Phase 4Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Nov 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of linaclotide (3 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Boston bowel preparation score. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
linaclotide
Beyond the preview
Go deeper on ChiCTR2200065832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065832.